New analysis

Mccormick + Co Non Vtg Shrs MKC

McCormick is a family-stewarded spice monopoly trading at a real discount.

McCormick is a family-stewarded spice monopoly trading at a real discount.

Mccormick + Co Non Vtg Shrs (MKC) · Analysis #1 · 5/4/2026

MKC dominates retail spices and flavor solutions with a 130+ year brand built on shelf real estate that competitors cannot replicate. At 17x earnings versus a 24x ten-year average and well below even the conservative IV, the price compensates for a temporary slowdown in organic growth and elevated post-Cholula leverage.

Plain English

McCormick makes the spices in your kitchen. The red-tin pepper, the mustard, the hot sauce, the seasoning packets. They have done this since 1889. They sell to grocery stores, and they sell flavor blends to companies that make snacks and frozen meals. They are by far the biggest spice company in America. They make money because (1) almost nobody starts a new spice brand and wins, and (2) once you grow up using McCormick, you keep buying it without thinking. The risk is that store brands get cheaper and people notice. The stock is on sale today.

Thesis

McCormick (MKC) sells flavor: spices, seasoning mixes, hot sauces, and B2B flavor systems to packaged-food makers. The Consumer segment is anchored by the McCormick red-cap tin, French's mustard, Frank's RedHot, Cholula, Old Bay, and Lawry's; the Flavor Solutions segment is the formulation partner inside many of the food brands you eat without thinking about it. The business is the textbook 'sell brands, buy commodities' set up canon excerpt [2] from Buffett 2011 calls 'a formula for business success' that produced compounding for Coca-Cola and Wrigley.

The scorecard is mixed but informative. ROIC is 9.6% on a ten-year average (decent, not great, dragged by ~$8B of goodwill from RB Foods and Cholula). ROIIC over the last five years is only 2.4% which is a yellow flag: capital ploughed into Cholula at a high multiple in 2020 plus elevated working capital have not yet earned their keep. FCF conversion of 43.7% is poor for a CPG, reflecting inventory build through inflation. Net debt/EBITDA sits at 2.7x, interest coverage 5.1x, manageable but not pristine. The share count is up 8.6% over ten years; this is an anti-buyback story management funds the dividend and pays down deal debt rather than retiring stock.

The valuation is the punchline. At $50.24 the stock trades at 17.25x TTM earnings versus a 17.25x to 23.76x ten-year average a 27% multiple compression. Owner earnings are $1.94B TTM. The deterministic IV range is $117 (low) to $224 (base) to $313 (high). Even granting the scorer's flag that maintenance capex is uncertain and the IV should be 'widened' (read: hair-cut), the price/IV ratio of 0.22 is extreme. You are paying for the legal moat and getting the growth optionality for free. Margin of safety becomes meaningful around the IV-low; you trim above the base IV.

Moat

Intangibles brand and shelf position (PRIMARY). McCormick's red-tin is the default spice brand in nearly every U.S. grocery store, and the company's category-captain relationships mean MKC literally manages the spice aisle planogram for many retailers. French's owns the yellow-mustard category at U.S. ballparks and barbecues. Frank's RedHot is the wing-sauce default. Cholula, Old Bay, Zatarain's, Lawry's each occupy a defensible cultural niche. Damodaran [6] makes the relevant point: brand value is built by 'the company's relentless focus on making its brand name more valuable globally,' and high ROE/ROIC is the consequence, not the cause. McCormick has done this for 135+ years, since 1889.

The stress test: could a $10B competitor displace McCormick over five years? Almost certainly not in the consumer business. Spices are a low-ticket, high-frequency, infrequent-decision category the consumer grabs the familiar tin and moves on. Slotting fees, planogram control, and 130-year brand recognition mean a new entrant would have to subsidize shelf space at a loss for years to even be tried. Private label has gnawed at the perimeter (Costco's Kirkland blends, Trader Joe's house spices) but McCormick's branded share of U.S. spices remains roughly 40%+ and growing where it competes. Compare to Buffett's See's Candy [5]: 'only three companies have earned more than token profits over the last forty years' the spice category has similar economics, just with more SKUs.

Cost advantage scale in sourcing (SECONDARY). McCormick is the largest single buyer of vanilla, black pepper, and many other spices globally. It hedges and stockpiles in commodity downturns, sells branded product through retail at sticky prices an embodiment of canon excerpt [2] 'buy commodities, sell brands.' This shows up as gross margins of 36 to 38%, well above private-label co-packers.

Switching costs Flavor Solutions (NARROW). The B2B segment formulates proprietary flavor systems for food manufacturers (think the seasoning blend on a specific QSR chicken sandwich). Once a customer's product is built around an MKC formulation and that formulation is qualified through food-safety audits, swapping vendors requires reformulation, re-testing, and risk to the customer's own brand. This is genuine, but narrower and lower-margin than the consumer moat; competitors include Givaudan, Symrise, IFF, ADM that compete vigorously.

Network effects. None. Spices do not get better when more people use them.

Pricing power. Real but rationed. McCormick took multiple price increases in 2021-2023 to pass through commodity inflation; elasticity has now turned against them and 2024-2025 volumes softened as private-label took share at the unit level. The pricing power exists but is not unlimited.

Erosion risks. (1) Private-label inflation from Aldi/Lidl/Costco model spreading further into mainstream grocery. (2) Amazon and direct-to-consumer disintermediating the slotting-fee moat over a 10-year horizon (a real concern, but spices are still mostly an in-store impulse category). (3) Consumer migration toward fresh herbs and meal kits at the margins. (4) GLP-1 weight-loss drugs reducing snacking volumes (modest effect on spice attach rate). (5) Goodwill impairment risk: Cholula was paid for at ~6x sales in 2020 a top-tick price.

Competitor stress test. Imagine Kraft Heinz, Unilever, or Nestl decide to take MKC's spice aisle. They have the capital and shelf relationships. Yet none has tried at scale because the economics for a challenger are awful: McCormick's category-captain status means its data informs the planogram, retailer trust is established, and the per-SKU dollar volume is too small for a new entrant to amortize a marketing campaign against. The spice aisle is an 'unattractive prize' a margin-rich category small enough that the giants pick larger fights.

Moat verdict: WIDE on the consumer brand portfolio (the bulk of profits and the most durable piece). NARROW on Flavor Solutions. Aggregate: WIDE-leaning, but narrowing slightly as private label and channel shift erode the perimeter.

Management

McCormick is a 135-year-old company still meaningfully steered by founding-family voting interests via the dual-class structure (this analysis is on the non-voting MKC shares; voting MKC.V trades thinly and at a small premium). CEO Brendan Foley took over in 2024 from Lawrence Kurzius; the bench is a deep, slow-promotion culture. Communication quality on calls is honest and quantitative they were early to flag price-elasticity reversal in 2024 and did not pretend volumes were fine.

Reinvestment. Capex runs $250-$300M annually on a $7B revenue base modest, mostly capacity expansion in flavor solutions and digital/SAP investment. The bigger reinvestment story is brand support: McCormick spends 5-6% of sales on advertising and trade. The judgment here is mediocre: ROIIC over the last five years is just 2.4% (per scorecard). Capital has gone in faster than incremental profits have come out, mostly because the Cholula deal and capacity build for pandemic-era demand have not yet earned their cost of capital.

Acquisitions. This is the central capital-allocation question. Two bets define the modern era:

  • RB Foods (French's, Frank's RedHot, Cattlemen's) bought from Reckitt in 2017 for $4.2B at ~20x EBITDA. Strategic fit was excellent; the multiple was full but defensible because synergies were real and the brands were under-marketed.
  • Cholula bought in 2020 for $800M at ~6x sales (~25x EBITDA). This was a top-tick price during the pandemic hot-sauce craze. Cholula has performed adequately but was not the steal that French's was. Net: management overpaid at the margin in 2020. Goodwill on the balance sheet now exceeds $5B. Impairment risk is real but not imminent.

Debt. Net debt/EBITDA is 2.7x (per scorecard), down from ~5x post-RB Foods. Interest coverage is 5.07x adequate but not fortress. Management's stated priority since 2021 has been deleveraging, which is the right call. Once leverage is at ~2x management has signaled buybacks resume.

Buybacks. The scorecard tells the story: share count is up 8.6% over ten years. McCormick has been a net issuer (employee stock comp not fully offset). This is the single weakest item in the capital allocation report card. For a business with this kind of moat trading below IV, the absence of buyback discipline costs shareholders real money. Average buyback P/IV when they have repurchased: not provided, but management has historically not been opportunistic at the lows they bought heavily in 2017-2019 at ~30x P/E and not at all in 2024-2025 at 17x.

Dividends. This is the bright spot. McCormick has paid uninterrupted dividends for 100+ years and raised the dividend for 39 consecutive years a Dividend Aristocrat. Current yield is roughly 3.5% at $50. Payout ratio is ~60% which is sustainable.

Communication. Above average. Quarterly disclosures are clean, segment reporting is honest, the family-influenced culture seems to discourage hype. They flagged inventory destocking and elasticity reversal early.

Capital allocator: B-. Operating execution is strong; brand stewardship is excellent; dividends are exemplary. But Cholula was a poor price, the RB Foods leverage took five years to digest, and the absence of buybacks at today's discount is a real demerit. Family-stewardship culture explains the conservatism but does not excuse the missed buyback opportunity.

Industry

Five Forces analysis of branded spices and flavor solutions.

1. Rivalry low-to-medium. The U.S. branded-spice category is a near-duopoly between McCormick and a long tail of regional and private-label producers. McCormick's share is roughly 40%+ in branded U.S. retail spice; the next largest branded competitor (Spice Islands/B&G Foods, Badia, Goya in ethnic adjacencies) is a fraction of MKC's scale. In Flavor Solutions the rivalry is more intense McCormick competes with Givaudan, Symrise, IFF, ADM, Kerry Group across geographies and customer segments. Industry growth is low-single-digits volumetric, with price/mix layered on top.

2. Buyer power varies by segment.

  • Consumer segment: retailers (Walmart, Kroger, Costco, Aldi) hold significant power and have leveraged it to push private label. Costco's Kirkland spices are a real threat at the high-velocity SKU level. But because McCormick is the category captain it advises the retailer on assortment, which gives it informational leverage in price negotiations.
  • Flavor Solutions: large CPG and QSR customers are sophisticated and demanding. Switching costs (reformulation, qualification) blunt the buyer power; multi-year supply contracts are common. Net: medium buyer power, somewhat blunted by category-captain economics and switching frictions.

3. Supplier power medium. Spice supply chains are global, weather-sensitive, and geopolitically fragile (vanilla in Madagascar, black pepper in Vietnam, paprika in eastern Europe). McCormick's scale and long-term sourcing relationships are an advantage suppliers prefer dealing with the largest buyer who pays on time. But individual commodity shocks (a Madagascar cyclone, a Vietnamese harvest failure) create periodic margin pressure that even McCormick cannot fully hedge.

4. Threat of new entrants low (consumer), medium (flavor solutions). A new branded spice entrant faces the slotting-fee + brand + category-captain triple-lock; this is why no major new entrant has emerged in 30 years. In Flavor Solutions, technical barriers (R&D, food-safety qualification, customer relationships) are real but lower than in fragrance or pharmaceutical flavor; new entrants from China and India compete on cost.

5. Threat of substitutes medium and slowly rising.

  • Fresh herbs and meal kits substitute for dried spices at the margin.
  • Direct-from-source online players (Burlap & Barrel, Diaspora Co.) cherry-pick the premium niche.
  • Most threateningly: home-cooking declines if GLP-1 drugs and continued restaurant share-of-stomach growth shift eating away from the kitchen, that erodes the entire category over a decade.

Value pool location and trajectory. Value sits in branded retail spices (highest gross margin) and increasingly in Flavor Solutions for the higher-end customers (custom seasoning systems for QSR, snack flavors). The pool is growing in dollars roughly 3-4% per year globally, but unit volumes are flat in mature markets; growth is in price/mix, emerging markets (India, China), and value-added flavor systems.

Industry Verdict: Good. Not great enough to be 'Excellent' (private label and channel-shift erosion are real), but well above 'Average' on durability, predictability, and gross margin profile. A 50-year horizon is plausible.

Inversion

The bear case for McCormick. I am playing a short-seller.

1. The single event that kills this. A multi-year, structural acceleration of private-label penetration in the spice aisle, catalyzed by Aldi-style hard-discount expansion in U.S. grocery and Costco's continued Kirkland push. The blueprint exists: in dairy, paper goods, and OTC pharma, private label has taken 25-40% volume share over ten years from incumbents that 'had moats.' If Costco's Kirkland organic spices reach $1B in U.S. revenue (plausible by 2030) and Aldi's 2,500-store U.S. footprint matures, MKC's volumes go negative for five consecutive years. Once volume turns structurally negative in a fixed-cost manufacturing footprint, gross margins compress and the 'moat' thesis becomes a melting-ice-cube thesis. The kill shot is not a single quarter; it is a slow-bleed erosion that becomes obvious in 2027-2029 hindsight.

2. Why the moat is narrower than bulls think. Bulls point to 40% category share, category-captain status, and 135 years of brand. The bear notes:

  • Category-captain status is a retailer-granted privilege, not a moat. The retailer can revoke it; Walmart did exactly this to several CPG categories in the 2010s.
  • 'Brand loyalty' in spices is largely habit + shelf placement, not affection. When Costco shows the consumer a 50% cheaper Kirkland alternative right next to the McCormick tin (which Costco does), conversion happens. The brand premium evaporates faster than in true affection categories like Coca-Cola.
  • Frank's RedHot and Cholula compete in hot sauce, where there are now 200+ craft hot-sauce SKUs and consumer fragmentation is real Tabasco, Sriracha, Cholula, Frank's, Yellowbird, Truff have all grown but at each other's marginal expense.
  • Flavor Solutions has narrow switching costs that the bulls oversell. Reformulation happens routinely when food companies cost-engineer; private-label flavor houses like Sensient and Kerry actively pitch on price.

3. Why management is worse than it appears. The Cholula acquisition at $800M / ~6x sales in 2020 was a textbook top-of-cycle, hot-sauce-craze deal. The same management team paid full freight in 2017 for RB Foods (now justified by hindsight, but at the time deeply leveraged the balance sheet to 5x EBITDA). Management issued shares through stock comp at a net 8.6% increase over ten years a self-inflicted destruction of per-share value. They did not buy back at today's 17x P/E, despite stated capacity to do so. This is not Buffett-style capital allocation; this is corporate-stewardship capital allocation. Family influence (the dual-class structure) reinforces conservatism that protects management more than shareholders. A Buffett-grade allocator would have hoarded cash in 2020 instead of paying 6x sales for Cholula and would be aggressively buying back stock today.

4. What bulls are extrapolating that won't hold.

  • Bulls extrapolate the 2017-2021 organic-growth rate of 4-5%. The actual go-forward rate is more likely 1-3% as price/mix runs out and volumes stay flat-to-down.
  • Bulls extrapolate margin recovery to pre-pandemic 18%+ operating margins. With private-label pressure and continued promotional intensity, the more likely steady-state is 16-17%.
  • Bulls extrapolate a re-rating back to the 24x ten-year P/E. But the 24x average was set during the 2014-2021 ZIRP era; in a 4%+ rate world the right multiple for a 2-3% organic grower is closer to 18-20x.
  • Bulls assume the IV scorecard at $224 base is reliable. The scorer itself flags maintenance capex uncertainty over 50% spread and recommends widening the IV range. The honest read is that the scorer's IV is somewhere between $80 and $300, and the cleaner DCF using a more conservative growth assumption (2%) and proper maintenance capex puts fair value closer to $80-100.
  • FCF conversion of only 43.7% over five years is a red flag bulls handwave away. CPG companies like McCormick should convert 80-100% of net income to FCF. The 43.7% figure says working capital is bleeding capital that the IV math treats as 'temporary.'

5. Valuation trap (multiple compression / regime change). At $50 the stock is 17x earnings and looks 'cheap' versus its 24x average. But the average was earned in a different regime: 0% rates, growing center-store grocery share, no GLP-1 drugs, no Aldi/Lidl, no Costco scale on house brands, no e-commerce disintermediation. If the steady-state P/E for this kind of slow-grower is 16-18x in the new regime, then today's price is fair, not cheap. The IV math depending on a doubling of multiple plus organic growth of 4%+ is the trap. ROIIC of 2.4% over the last five years (per scorecard) is not what a 'compounder' looks like. A real compounder earns 15%+ on incremental capital. McCormick is earning 2.4% the dividend is doing the work, not the business.

Verdict. Decompose the bear: (a) terminal multiple compresses to 14-16x as growth slows, (b) operating margins settle at 16% not 18%, (c) revenue grows 1.5%/year not 4%, (d) FCF conversion stays at 60% not 80%. Owner earnings at $1.94B today might be $2.1B in five years on these assumptions, capitalized at 16x = $33.6B equity value, divide by ~270M shares = $124/share IV. The bull thesis dies if the regime change is real.

If I am right, the stock could be worth $35 within 3 years. A re-rating to 14x trough earnings of $2.50 on softer volumes plus continued share count drift gives a fair price around $35, a 30% downside from $50.

Lollapalooza Bias Check

Active biases in this analyst right now.

Authority bias / canon worship. The brief feeds canon excerpts that explicitly endorse the 'sell brands, buy commodities' [2] thesis and the See's Candy [5] niche-monopoly archetype. McCormick fits the template almost perfectly which is exactly the danger. The temptation is to pattern-match to See's and Coca-Cola and grant MKC the same compounding economics, when the actual ROIIC of 2.4% says it is not in fact compounding the way See's compounds. I noticed myself reaching for the See's analogy three times while writing the moat section. Discounting that bias pulls fair value down.

Anchoring on IV print. The scorecard says IV-base of $224 versus $50 price; px/IV of 0.22. That is an anchor that screams 'screaming buy.' But the scorer itself flagged maintenance capex uncertainty twice 'widen IV range' is the polite way to say 'I do not trust this number.' Anchoring on $224 produces a Strong Buy; honest treatment produces a Buy with much wider error bars. I am consciously dialing back conviction because of this.

Recency bias on quality consumer staples. In 2023-2024, market sentiment turned against staples (CHD, CLX, KHC, MKC all derated). My recency-weighted mental model of staples is more pessimistic than my long-cycle model. This pushes me to be too negative on the inversion. I tried to compensate but probably under-corrected.

Confirmation bias the family-stewardship narrative. The 100-year dividend record and the 39-year increase streak are emotionally appealing facts that support a 'forever-hold' narrative. I notice myself wanting to assume 'the family will not let it fail,' which is not a quantitative argument. Family-controlled companies fail too (see WeightWatchers, Bed Bath, etc., though admittedly different categories).

Deprival super-reaction. The stock was $90+ in 2020-2022. Investors who held are now 'down 45%' and reluctant to sell. New buyers are tempted to anchor on the old price. I am working from the current price, not the old price, but the anchoring effect is in the public discourse around MKC and may be inflating the 'cheap' narrative.

Incentive bias. I was hired to write a Buffett-style analysis of a Buffett-style company. The brief itself selects for findings that endorse the Buffett framework. If MKC were terrible, I would still feel pressure to find a 'compounder' angle. I am consciously offsetting by giving the inversion full weight.

Net effect of biases. They push toward Buy. Adjusting for them, I land at Buy with medium conviction rather than Strong Buy with high conviction.

10-Year Outlook

Ten-year forward test.

Same fundamental business model? Largely yes. McCormick will still sell branded spices and flavor solutions in 2036. The product mix shifts (more premium, more organic, more convenience-formats), but the model 'buy commodity, sell brand' is durable.

Customer base larger? Probably modestly. Population growth + emerging-market penetration + flavor-trend tailwinds (more home cooking interest, more global cuisine adoption) add roughly 1-2% per year to addressable units. Headwinds (private label, GLP-1, restaurant share-of-stomach) subtract 0.5-1.5%. Net: customer count flat-to-modestly-positive.

Profit per customer higher? This is the swing variable. Bull case: yes, via Flavor Solutions premium-mix shift, value-added seasoning blends, and pricing power compounding at GDP+. Bear case: no private-label trade-down compresses ASPs even as costs rise. Reasonable forecast: per-customer profit grows at low-single-digits real, in line with category dollar growth.

Moat wider? Probably not. The consumer brand moat is mature already wide; not many bricks left to add. The Flavor Solutions moat could widen incrementally through SAP/digital investment and customer-specific formulation IP. But channel disintermediation (e-commerce, direct-from-source) gnaws at the margin. Net: moat width roughly flat to slightly narrower.

Single biggest threat? Private-label penetration in U.S. grocery, accelerated by hard-discount and Costco. This is the structural shift to watch. Secondary: e-commerce changing the spice purchase from 'in-aisle impulse' to 'subscription/replenishment' which favors direct-from-source merchants over McCormick's brand premium.

Confidence assessment. The business is durable; the return on capital is the uncertainty. ROIIC of 2.4% over the last five years means the business is not currently compounding. If the next five years see ROIIC return to 8-10% (deleveraging completes, Cholula matures, Flavor Solutions mix shifts), the IV is real. If ROIIC stays at 2-4%, the IV math is wrong and fair value is closer to the bear-case $80-100.

CONFIDENCE: medium

Position Guidance

  • Recommendation: Buy
  • Conviction: Medium
  • Target buy price: $50 (current price is already at margin of safety vs IV-low of $117; aggressive accumulation under $55, full position under $50, back-up-the-truck under $40)
  • Target trim price: $130 (start trimming as price approaches IV-low; trim materially above $200 toward IV-base; exit above $280)
  • Position sizing: 2-4% of portfolio. Not a 'concentrate' position because (a) ROIIC of 2.4% is too weak for a 5%+ position, (b) maintenance capex uncertainty in the IV is real, (c) management's buyback discipline is poor. Treat as a high-quality slow-compounder dividend payer with optionality, not as a Buffett-grade compounder.